blow the whistle
$show the love

Drug companies reduce payments to doctors as scrutiny mounts

January 4, 2012 --

Some of the nation’s top medical schools cracked down on professors who give paid promotional talks for drugmakers last year, and the firms themselves cut back on such spending in the wake of mounting scrutiny. ProPublica first published its Dollars for Docs database in October 2010 listing payments to doctors from seven drug companies. When we updated it this September — with data from five additional companies — spending by some of the firms was down.

More drug companies reveal payments to doctors

September 8, 2011 --

By CHARLES ORNSTEIN, TRACY WEBER and DAN NGUYEN/ProPublica Eight pharmaceutical companies, including the nation’s three largest, doled out more than $220 million last year to promotional speakers for their products, according to a ProPublica analysis of company data. For the first time, all these companies have reported a full year of payments, allowing for head-to-head […]

Drugmaker paid psychiatrist $490K to promote antipsychotic, despite doubts about research

Drugmaker paid psychiatrist $490K to promote antipsychotic, despite doubts about research
November 13, 2009 --

Over a decade-long period, AstraZeneca paid Chicago’s Michael Reinstein nearly half a million dollars to promote their antipsychotic. However, internal emails show that executives had doubts about Reinstein’s claim that their drug, Seroquel, helped patients lose weight.